NCT07291401 2025-12-18
Radiotherapy Plus CAPOX, and Iparomlimab and Tuvonralimab (QL1706) as Neoadjuvant Therapy for LARC
Zhongnan Hospital
Phase 2 Not yet recruiting
Zhongnan Hospital
The First Affiliated Hospital of University of Science and Technology of China